121 related articles for article (PubMed ID: 27903997)
21. Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity.
Ebrahimi M; Ghayour-Mobarhan M; Rezaiean S; Hoseini M; Parizade SM; Farhoudi F; Hosseininezhad SJ; Tavallaei S; Vejdani A; Azimi-Nezhad M; Shakeri MT; Rad MA; Mobarra N; Kazemi-Bajestani SM; Ferns GA
Acta Cardiol; 2009 Jun; 64(3):321-7. PubMed ID: 19593941
[TBL] [Abstract][Full Text] [Related]
22. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients with Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial.
Agh F; Mohammadzadeh Honarvar N; Djalali M; Nematipour E; Gholamhoseini S; Zarei M; Ansari S; Javanbakht MH
Arch Iran Med; 2017 Jan; 20(1):28-33. PubMed ID: 28112528
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Stein EA; Bays HE; Maki KC; Doyle RT; Shalwitz RA; Ballantyne CM; Ginsberg HN;
Clin Ther; 2007 Jul; 29(7):1354-67. PubMed ID: 17825687
[TBL] [Abstract][Full Text] [Related]
24. Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride levels.
Berge K; Musa-Veloso K; Harwood M; Hoem N; Burri L
Nutr Res; 2014 Feb; 34(2):126-33. PubMed ID: 24461313
[TBL] [Abstract][Full Text] [Related]
25. Effect of high-dose Omega 3 on lipid profile and inflammatory markers in chronic hemodialysis children.
Omar ZA; Montser BA; Farahat MAR
Saudi J Kidney Dis Transpl; 2019; 30(3):634-639. PubMed ID: 31249227
[TBL] [Abstract][Full Text] [Related]
26. Supplementation with omega-3 acids after myocardial infarction and modification of inflammatory markers in light of the patients' diet: a preliminary study.
Makarewicz-Wujec M; Parol G; Parzonko A; Kozłowska-Wojciechowska M
Kardiol Pol; 2017; 75(7):674-681. PubMed ID: 28394002
[TBL] [Abstract][Full Text] [Related]
27. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
28. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG; Jitomir J; Wilson RL; Gentile M
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of peripheral arterial disease in hemodialysis patients.
Jabbari M; Kazemi Jahromi M; Bahar N; Yousefi-Far ES; Arabi M; Asefi N; Mahmoudian A
Iran J Kidney Dis; 2012 Nov; 6(6):441-5. PubMed ID: 23146982
[TBL] [Abstract][Full Text] [Related]
30. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study.
Szklarek-Kubicka M; Fijałkowska-Morawska J; Zaremba-Drobnik D; Uciński A; Czekalski S; Nowicki M
J Ren Nutr; 2009 Nov; 19(6):487-93. PubMed ID: 19616450
[TBL] [Abstract][Full Text] [Related]
31. Omega 3 fatty acids effect on the vascular calcification biomarkers fetuin A and osteoprotegerin in hemodialysis patients.
Werida RH; Abou-Madawy S; Abdelsalam M; Helmy MW
Clin Exp Med; 2022 May; 22(2):301-310. PubMed ID: 34286397
[TBL] [Abstract][Full Text] [Related]
32. Effect of omega-3 fatty acid on oxidative stress in patients on hemodialysis.
Tayyebi-Khosroshahi H; Houshyar J; Tabrizi A; Vatankhah AM; Razzagi Zonouz N; Dehghan-Hesari R
Iran J Kidney Dis; 2010 Oct; 4(4):322-6. PubMed ID: 20852375
[TBL] [Abstract][Full Text] [Related]
33. A randomized-controlled clinical trial investigating the effect of omega-3 fatty acids and vitamin E co-supplementation on markers of insulin metabolism and lipid profiles in gestational diabetes.
Taghizadeh M; Jamilian M; Mazloomi M; Sanami M; Asemi Z
J Clin Lipidol; 2016; 10(2):386-93. PubMed ID: 27055970
[TBL] [Abstract][Full Text] [Related]
34. Associations between Omega-3 Index increase and triacylglyceride decrease in subjects with hypertriglyceridemia in response to six month of EPA and DHA supplementation.
Schuchardt JP; Neubronner J; Block RC; von Schacky C; Hahn A
Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):129-34. PubMed ID: 25108576
[TBL] [Abstract][Full Text] [Related]
35. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H
J Am Nutr Assoc; 2022; 41(7):697-712. PubMed ID: 34635026
[No Abstract] [Full Text] [Related]
36. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients.
Su TC; Hwang JJ; Huang KC; Chiang FT; Chien KL; Wang KY; Charng MJ; Tsai WC; Lin LY; Vige R; Olivar JE; Tseng CD
J Atheroscler Thromb; 2017 Mar; 24(3):275-289. PubMed ID: 27600795
[TBL] [Abstract][Full Text] [Related]
37. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients.
An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Rha SH; Park Y
Nutr Res; 2012 Jul; 32(7):495-502. PubMed ID: 22901557
[TBL] [Abstract][Full Text] [Related]
38. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin.
El-Sharkawy H; Aboelsaad N; Eliwa M; Darweesh M; Alshahat M; Kantarci A; Hasturk H; Van Dyke TE
J Periodontol; 2010 Nov; 81(11):1635-43. PubMed ID: 20572767
[TBL] [Abstract][Full Text] [Related]
39. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.
Jacobson TA; Glickstein SB; Rowe JD; Soni PN
J Clin Lipidol; 2012; 6(1):5-18. PubMed ID: 22264569
[TBL] [Abstract][Full Text] [Related]
40. Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial.
Neil HA; Ceglarek U; Thiery J; Paul S; Farmer A; Holman RR
Atherosclerosis; 2010 Dec; 213(2):512-7. PubMed ID: 21036355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
